Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Noxopharm Ltd. (AU:NOX)
ASX:NOX
Noxopharm Ltd. (NOX) Share Price & Analysis
1 Followers
NOX Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.03 - AU$0.17
Previous CloseAU$0.06
Volume56.76K
Average Volume (3M)181.90K
Market Cap
AU$18.41M
Enterprise ValueAU$4.56M
Total Cash (Recent Filing)AU$14.01M
Total Debt (Recent Filing)AU$160.62K
Price to Earnings (P/E)-1.5
Beta-0.43
Next Earnings
Aug 29, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding292,237,950
10 Day Avg. Volume1,326,352
30 Day Avg. Volume181,897
Standard Deviation0.31
R-Squared0.08
Alpha0.05
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Noxopharm Ltd. News
PremiumCompany Announcements
Noxopharm Bolsters Biotech Influence Globally
PremiumCompany Announcements
Noxopharm Secures Funding for Brain Cancer Drug ResearchOptions Prices
Currently, No data available
---
Ownership Overview
16.07% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
83.93% Public Companies and
Individual Investors
NOX FAQ
What was Noxopharm Ltd.’s price range in the past 12 months?
Noxopharm Ltd. lowest share price was AU$0.03 and its highest was AU$0.17 in the past 12 months.
What is Noxopharm Ltd.’s market cap?
Currently, no data Available
When is Noxopharm Ltd.’s upcoming earnings report date?
Noxopharm Ltd.’s upcoming earnings report date is Aug 29, 2024 which is in 107 days.
How were Noxopharm Ltd.’s earnings last quarter?
Noxopharm Ltd. released its earnings results on Feb 26, 2024. The company reported -AU$0.009 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.009.
Is Noxopharm Ltd. overvalued?
According to Wall Street analysts Noxopharm Ltd.’s price is currently Overvalued.
Does Noxopharm Ltd. pay dividends?
Noxopharm Ltd. does not currently pay dividends.
What is Noxopharm Ltd.’s EPS estimate?
Noxopharm Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Noxopharm Ltd. have?
Noxopharm Ltd. has 292,237,950 shares outstanding.
What happened to Noxopharm Ltd.’s price movement after its last earnings report?
Noxopharm Ltd. reported an EPS of -AU$0.009 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -14.286%.
Which hedge fund is a major shareholder of Noxopharm Ltd.?
Currently, no hedge funds are holding shares in AU:NOX
---
Noxopharm Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:NOX Sentiment 100%
Sector Average 70%
Sector Average 70%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
34.04%
12-Months-Change
Fundamentals
Return on Equity
-95.95%
Trailing 12-Months
Asset Growth
-67.35%
Trailing 12-Months
Company Description
Noxopharm Ltd.
Noxopharm Ltd is an Australian clinical-stage drug development company focused on treating cancer with Veyonda. It is engaged in the development in the field of both oncology and non-oncology in the pan-pacific region.
---
Technical Analysis
---